WW International (WW), more commonly known as Weight Watchers, is fully embracing the popularity of GLP-1s and their impact on weight loss management with a new platform that integrates GLP-1 ...
NEW YORK, Dec. 16, 2025 (GLOBE NEWSWIRE) -- WW International, Inc. (WW) (“Weight Watchers”), the global leader in science-backed weight management, today introduced a new, fully integrated experience ...
The addition of Ozempic® pill will give Weight Watchers Med+ members a new FDA-approved oral GLP-1 option for adults living with type 2 diabetesNEW YORK, May 01, 2026 (GLOBE NEWSWIRE) -- WW ...
Through expanded collaboration with Novo Nordisk, eligible Med+ members can now save up to $1,200 per year on Wegovy®, increasing affordable access to FDA-approved GLP-1 treatment leveraging Weight ...
Weight Watchers announced a new weight loss program for people with type 2 diabetes, which it will provide through its employee wellness offering. The new program, called Weight Watchers for Diabetes, ...
WW Clinic is a telehealth service from WW (formerly WeightWatchers) that integrates FDA-approved weight loss medication with WW behavioral coaching and diet tracking tools. GLP-1 medications are ...
A redesigned Weight Watchers experience pairs GLP-1 prescriptions with personalized nutrition, coaching, community support, and cutting-edge technology to help members meet their weight loss goals and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results